RNLXYOTCServices-Medical LaboratoriesFiscal year ends June 30Also trades as RENXF
Renalytix plc
Financials through Q1 FY2025, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$3.56+0.06 (+1.57%)
Close on Oct 19, 2026
- Market cap
- $375.75M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Renalytix has not reported a dividend
No dividend per share appears in Renalytix's annual filings since fiscal 2018.